1.Clinical analysis, diagnosis, and treatment of a 48-year-old female Filipino with Riehl melanosis
Maria Jenina P. Aguado ; Elizabeth Ryan ; Johannes F. Dayrit
Journal of the Philippine Dermatological Society 2020;29(1):109-117
INTRODUCTION: Pigmented contact dermatitis (PCD) is characterized by non-eczematous pigmentation associated with contact sensitizers, usually without any active or preceding pruritus and erythema. PCD was first described by Riehl, who identified patients with brown to gray facial pigmentation concentrated on the face most commonly associated with sensitizing chemical such as cosmetics, fragrances, and textiles.
CASE REPORT: This is a case of a 48-year-old female Filipino who presents with blue-grey to brown patches on the forehead of 1-year duration with no significant pathologic history. Clinical examination, dermoscopy and histology were consistent with a variant of pigmented contact dermatitis known as Riehl melanosis. Since anamnesis was unremarkable, patch testing was done to identify the contact allergen triggering the symptom. Results obtained a positive reaction to nickel, potassium dichromate, and textile dye.
CONCLUSION:Treatment includes the elimination of trigger factors, hence the importance of patch testing in the investigation of its cause. Alongside adequate photoprotection, a combination treatment of 1,064 nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser, 20% tricholoacetic acid (TCA) peel and oral retinoids, were found safe and effective in the management of facial melanosis. Three-dimensional imaging and dermoscopy were utilized to obtain a more standard and objective pre- and post-treatment comparison.
Lasers, Solid-State
;
Patch Tests
;
Melanosis
;
Skin Abnormalities
;
Dermatitis, Contact
2.Strategies for Management of Peritoneal Dialysis Patients in Singapore during COVID-19 Pandemic.
Htay HTAY ; Penelope Maxine P K WONG ; Rui-En Ryan CHOO ; Ubaidullah S DAWOOD ; Marjorie Wai Yin FOO ; Mathini JAYABALLA ; Grace LEE ; Martin Beng-Huat LEE ; Ya Lun Allen LIU ; Sanmay LOW ; Alvin Kok Heong NG ; Elizabeth Ley OEI ; Yong Pey SEE ; Rajat TAGORE ; Yinxia TAI ; Adrian LIEW
Annals of the Academy of Medicine, Singapore 2020;49(12):1025-1028
Peritoneal dialysis (PD) is the only well-established home-based dialysis therapy in Singapore. As it is a home-based modality, PD should be considered as a preferred mode of kidney replacement therapy (KRT) for patients with kidney failure during this COVID-19 pandemic as it avoids frequent visits to hospitals and/or satellite dialysis centres. The highly infectious nature of this virus has led to the implementation of the Disease Outbreak Response System Condition orange status in Singapore since early February 2020. This paper summarises the strategies for management of several aspects of PD in Singapore during this COVID-19 pandemic, including PD catheter insertion, PD training, home visit and assisted PD, outpatient PD clinic, inpatient management of PD patients with or without COVID-19 infection, PD as KRT for COVID-19 patients with acute kidney injury, management of common complications in PD (peritonitis and fluid overload), and management of PD inventory.
Ambulatory Care/methods*
;
COVID-19/prevention & control*
;
Home Care Services
;
Hospitalization
;
Humans
;
Infection Control/methods*
;
Pandemics
;
Peritoneal Dialysis/methods*
;
Self Care/methods*
;
Singapore/epidemiology*
3.Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH).
Kelsey A CARPENTER ; Delia O ALKHATIB ; Bryan A DULION ; Elizabeth GUIRADO ; Shreya PATEL ; Yinghua CHEN ; Anne GEORGE ; Ryan D ROSS
International Journal of Oral Science 2023;15(1):47-47
X-linked hypophosphatemia (XLH) is a rare disease of elevated fibroblast growth factor 23 (FGF23) production that leads to hypophosphatemia and impaired mineralization of bone and teeth. The clinical manifestations of XLH include a high prevalence of dental abscesses and periodontal disease, likely driven by poorly formed structures of the dentoalveolar complex, including the alveolar bone, cementum, dentin, and periodontal ligament. Our previous studies have demonstrated that sclerostin antibody (Scl-Ab) treatment improves phosphate homeostasis, and increases long bone mass, strength, and mineralization in the Hyp mouse model of XLH. In the current study, we investigated whether Scl-Ab impacts the dentoalveolar structures of Hyp mice. Male and female wild-type and Hyp littermates were injected with 25 mg·kg-1 of vehicle or Scl-Ab twice weekly beginning at 12 weeks of age and euthanized at 20 weeks of age. Scl-Ab increased alveolar bone mass in both male and female mice and alveolar tissue mineral density in the male mice. The positive effects of Scl-Ab were consistent with an increase in the fraction of active (nonphosphorylated) β-catenin, dentin matrix protein 1 (DMP1) and osteopontin stained alveolar osteocytes. Scl-Ab had no effect on the mass and mineralization of dentin, enamel, acellular or cellular cementum. There was a nonsignificant trend toward increased periodontal ligament (PDL) attachment fraction within the Hyp mice. Additional PDL fiber structural parameters were not affected by Scl-Ab. The current study demonstrates that Scl-Ab can improve alveolar bone in adult Hyp mice.
Mice
;
Male
;
Female
;
Animals
;
Familial Hypophosphatemic Rickets/metabolism*
;
Bone and Bones/metabolism*
;
Tooth/metabolism*
;
Periodontal Ligament/metabolism*